| Business Type | Exporter, Supplier, Retailer |
| Size | 420 mg,420 mg / 14 mL vial |
| Type | oncology biologic |
| Material | Pertuzumab |
| Click to view more | |
Product Details
Brand Name
Perjeta
Color
colorless
Form
Injection
Usage
Hospital
Country of Origin
USA
Port
California
Payment Terms
T/T, Western Union, Other
Delivery Time
3 days
Packaging Details
Single-dose glass vial with rubber stopper and aluminum seal
Supplied in a protective carton with labeling and prescribing information
Stored at 2°C–8°C (36°F–46°F); do not freeze; protect from light
Supplied in a protective carton with labeling and prescribing information
Stored at 2°C–8°C (36°F–46°F); do not freeze; protect from light
Perjeta (pertuzumab) is a prescription biologic medicine used in the treatment of HER2-positive breast cancer. It is a monoclonal antibody designed to work in combination with trastuzumab (Herceptin) and chemotherapy to improve treatment outcomes in patients with aggressive HER2-driven disease.
Perjeta inhibits cancer growth by:
-
Preventing HER2 dimerization with other HER family receptors (HER1, HER3, HER4)
-
Blocking downstream signaling pathways responsible for tumor growth and survival
-
Enhancing immune-mediated destruction of cancer cells
Email: peptidevera@
Looking for "Perjeta Pertuzumab 420mg Injection" ?
Box
